Status:
RECRUITING
Monitoring of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomography
Lead Sponsor:
University of Erlangen-Nürnberg Medical School
Conditions:
Crohn Disease
Ulcerative Colitis
Eligibility:
All Genders
2-18 years
Brief Summary
In this clinical trial, the intestinal wall of pediatric patients with Crohns disease and Ulcerative Colitis will be assessed with multispectral optoacoustic tomography (MSOT) to characterize the opto...
Detailed Description
In this study, the disease activity of children and adolescents with inflammatory bowel disease (IBD) will be assessed non-invasively by multispectral optoacoustic tomography (MSOT). IBDs play an impo...
Eligibility Criteria
Inclusion
- Existing diagnosis of CD or UC, or suspected CD or UC at initial diagnosis.
- Age 2 - 18 years
- Written declaration of consent from parents / legal guardians
Exclusion
- Pregnancy
- Nursing mothers
- Cardiopulmonary unstable patients\*: Need for continuous cardiopulmonary monitoring
- Tattoo in the area of the examination field
- Subcutaneous fat \> 3 cm
Key Trial Info
Start Date :
January 24 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06107179
Start Date
January 24 2024
End Date
February 1 2026
Last Update
February 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Erlangen
Erlangen, Bavaria, Germany, 91054